about
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisGenome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesisDifferential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.Perilipin polymorphisms are risk factors for the development of obesity in adolescents? A case-control study.Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population.Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.Heparin treatment increases thioredoxin interacting protein expression in hepatocellular carcinoma cells.Silencing of TRPC1 regulates store-operated calcium entry and proliferation in Huh7 hepatocellular carcinoma cells.MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells.The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma.The Genetics of Asymmetry: Whole Exome Sequencing in a Consanguineous Turkish Family with an Overrepresentation of Left-Handedness
P50
Q24298462-867E6A9A-1A78-44D4-AE9D-A23F78F1E4FCQ28488081-4502DC35-5B53-44B2-BA97-5D15EF07F1EDQ33411986-2EEFD414-2CEB-4DAB-ACB3-250F87F0936FQ34388854-DED1A805-B7A0-4D44-B4B5-07DC70D62172Q34479204-F76A6D92-508C-43C7-AEA8-63D5A70F1BC0Q35229808-C40F6B8C-93D7-4260-B39E-CF9905AB0717Q37405722-EEB602A2-B667-424B-ABC5-7DD1DB565E15Q37496251-D5076624-3759-427C-AAA2-CBC33733545BQ37690096-EFC6D5B1-FEAE-4AD2-9C4E-5AB344CE65D6Q38774214-951DC8E9-B875-4A68-AD85-5C268092F98AQ38801405-C23A2596-64EB-4B73-BA35-DC9A4597D127Q38868125-CD21B675-AA03-4DB2-8166-61C9E574DC8FQ38876884-8E8B2F0B-311E-485F-B915-C958207199BDQ38972160-3AECD0B2-08D6-416E-B868-81231C7A9257Q40456020-FF18D297-5CEC-4557-BA31-BF3EBEE05199Q42251558-02C6F9A4-E81B-4CFB-A372-BB972DC37FC4Q51012881-486C4B8C-FE53-4788-AD01-2BCA8A086301Q59109314-E9D7AB97-7FBA-4570-B07C-A25A33BAD82A
P50
description
researcher ORCID ID = 0000-0001-7264-0574
@en
wetenschapper
@nl
name
Esra Erdal
@ast
Esra Erdal
@en
Esra Erdal
@es
Esra Erdal
@nl
type
label
Esra Erdal
@ast
Esra Erdal
@en
Esra Erdal
@es
Esra Erdal
@nl
prefLabel
Esra Erdal
@ast
Esra Erdal
@en
Esra Erdal
@es
Esra Erdal
@nl
P106
P31
P496
0000-0001-7264-0574